🇺🇸 FDA
Patent

US 11021535

Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use

granted A61PA61P33/06

Quick answer

US patent 11021535 (Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P33/06